Charles M. Beasley - Publications, H-index & Citations

Charles M. Beasley

Eli Lilly

53H指数

181论文数

1.1W被引数

收录论文 43

发表时间

Oral olanzapine versus oral haloperidol in the maintenance treatment of schizophrenia and related psychoses

BRITISH JOURNAL OF PSYCHIATRY

IF7.6

2018-01-03

130

PREAI

Tran, PV; Dellva, MA; Tollefson, GD; Wentley, AL; Beasley, CM

Olanzapine and tardive dyskinesia - Author's reply

BRITISH JOURNAL OF PSYCHIATRY

IF7.6

2018-01-03

PREAI

Beasley, CM

Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol

BRITISH JOURNAL OF PSYCHIATRY

IF7.6

2018-01-02

192

PREAI

Beasley, CM; Dellva, MA; Tamura, RN; Morgenstern, H; Glazer, WM; Ferguson, K; Tollefson, GD

Olanzapine versus haloperidol in the treatment of schizoaffective disorder - Acute and long-term therapy

BRITISH JOURNAL OF PSYCHIATRY

IF7.6

2018-01-02

PREAI

Tran, PV; Tollefson, GD; Sanger, TM; Lu, YL; Berg, PH; Beasley, CM

Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizers

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2013-01-10

OAAI

Loghin, Corina; Haber, Harry; Beasley, Charles M., Jr.; Kothare, Prajakti A.; Kauffman, Lynnette; April, John; Jin, Ling; Allen, Albert J.; Mitchell, Malcolm I.

Changes in blood pressure and heart rate associated with atomoxetine treatment in attention-deficit/hyperactivity disorder

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2012-10-01

PREAI

Camporeale, A.; Beasley, C.; Tanaka, Y.; D'Souza, D.; Upadhyaya, H.

Evaluating suicide-related adverse events in clinical trials of fluoxetine treatment in adults for indications other than major depressive disorder

PSYCHOLOGICAL MEDICINE

IF5.5

2007-07-20

PREAI

Tauscher-Wisniewski, Sitra; Disch, Damon; Plewes, John; Ball, Susan; Beasley, Charles M., Jr.

Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes

PSYCHOTHERAPY AND PSYCHOSOMATICS

IF17.4

2006-12-08

PREAI

Perlis, Roy H.; Beasley, Charles M., Jr.; Wines, James D., Jr.; Tamura, Roy N.; Cusin, Cristina; Shear, Deborah; Amsterdam, Jay; Quitkin, Frederick; Strong, Robert E.; Rosenbaum, Jerrold F.; Fava, Maurizio

Effects of antipsychotic drugs on Ito, INa, Isus, IK1, and hERG:: QT prolongation, structure activity relationship, and network analysis

PHARMACEUTICAL RESEARCH

IF4.3

2006-05-25

PREAI

Crumb, William J., Jr.; Ekins, Sean; Sarazan, R. Dustan; Wikel, James H.; Wrighton, Steven A.; Carlson, Christopher; Beasley, Charles M., Jr.

Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: A randomized, double-blind, parallel, placebo-controlled clinical trial

JOURNAL OF SEXUAL MEDICINE

IF3.3

2005-09-01

PREAI

Carrier, S; Brock, GB; Pommerville, PJ; Shin, J; Anglin, G; Whitaker, S; Beasley, CM

Absence of clinically important HERG channel blockade by three compounds that inhibit phosphodiesterase 5 - sildenafil, tadalafil, and vardenafil

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2004-10-01

PREAI

Sarazan, RD; Crumb, WJ; Beasley, CM; Emmick, JT; Ferguson, KM; Strnat, CA; Sausen, PJ

A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil

EUROPEAN UROLOGY

IF25.2

2004-04-01

PREAI

von Keitz, A; Rajfer, J; Segal, S; Murphy, A; Denne, J; Costigan, T; Lockhart, D; Beasley, CM; Emmick, JT

The effectiveness of olanzapine versus placebo in maintaining the Quality of Life in stabilized patients with schizophrenia

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2003-10-01

PREAI

Beasley, CM; Walker, DJ; Sutton, VK; Alaka, K; Naber, D; Namjoshi, M

Tadalafil has no detrimental effect on human spermatogenesis or reproductive hormones

JOURNAL OF UROLOGY

IF6.8

2003-09-01

102

PREAI

Hellstrom, WJG; Overstreet, JW; Yu, A; Saikal, K; Shen, W; Beasley, CM; Watkins, VS

Effects of intramuscular olanzapine vs. haloperidol and placebo on QTc intervals in acutely agitated patients

PSYCHIATRY RESEARCH

IF3.9

2003-07-01

PREAI

Lindborg, SR; Beasley, CM; Alaka, K; Taylor, CC

When should a trial of fluoxetine for major depression be declared failed?

AMERICAN JOURNAL OF PSYCHIATRY

IF14.7

2003-04-01

PREAI

Quitkin, FM; Petkova, E; McGrath, PJ; Taylor, B; Beasley, C; Stewart, J; Amsterdam, J; Fava, M; Rosenbaum, J; Reimherr, F; Fawcett, J; Chen, Y; Klein, D

Prospective evaluation of insulin sensitivity by the hyperinsulinemic, euglycemic clamp in healthy volunteers treated with olanzapine, risperidone or placebo

SCHIZOPHRENIA RESEARCH

IF3.5

2003-03-01

PREAI

Beasley, CM; Sowell, MO; Carlson, C; Mukhopadhyay, N; Dananberg, J; Henry, R; Breier, A; Cavazzoni, P

Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2002-04-01

PREAI

Brunswick, DJ; Amsterdam, JD; Fawcett, J; Quitkin, FM; Reimherr, FW; Rosenbaum, JF; Beasley, CM

A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

IF2.8

2001-01-01

PREAI

Kennedy, JS; Bymaster, FP; Schuh, L; Calligaro, DO; Nomikos, G; Felder, CC; Bernauer, M; Kinon, BJ; Baker, RW; Hay, D; Roth, HJ; Dossenbach, M; Kaiser, C; Beasley, CM; Holcombe, JH; Effron, MB; Breier, A

Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: An updated meta-analysis

CLINICAL THERAPEUTICS

IF3.6

2000-11-01

PREAI

Beasley, CM; Koke, SC; Nilsson, ME; Gonzales, JS

研究方向